臭氧经血管介入途径对兔VX2肝癌的初步实验研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省科技创新苗子工程培育项目(2020090)


Preliminary experimental study on the effect of ozone via vascular intervention on rabbit vx2 liver cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探究臭氧水经肝动脉灌注途径处理兔VX2肝癌后的作用与安全性。方法 建立新西兰大白兔VX2肝癌模型,随机地把荷瘤兔分为臭氧水组与生理盐水组,每组20只,并介入手术干预。在术前1天、术后第1、3、5天采取耳缘静脉血,检测AST、ALT、Cr以及TNF-α、IL-6、IL-1β。在介入术后第7天、第14天做CT检查,计算肿瘤体积增长率,术后第28天时解剖荷瘤兔行病理检查。结果 臭氧经肝动脉灌注途径作用于兔VX2肝癌抑制肿瘤细胞的生长、促进肿瘤细胞坏死以及促进TNF-α、IL-6、IL-1β的释放,对荷瘤兔的肝肾功能无明显影响。结论 本研究证实臭氧水经肝动脉灌注途径作用于VX2肝癌的荷瘤兔是一种有效、安全的方法,值得进一步的研究探索

    Abstract:

    Objective To explore the role and safety of ozone water administered through hepatic artery infusion in rabbits with VX2 liver cancer.Methods A VX2 liver cancer model was established in New Zealand white rabbits, which were randomly divided into the ozone water group (n=20) and the saline group (n=20), and underwent surgical intervention. Blood samples were collected from the ear vein 1 day before surgery and on postoperative days 1, 3, and 5 to measure AST, ALT, Cr, TNF-α, IL-6, and IL-1β. CT scans were performed on postoperative days 7 and 14 to calculate tumor volume growth rates. Pathological examination was conducted on day 28 post-surgery. Results Ozone administered through hepatic artery infusion inhibited tumor cell growth, promoted tumor cell necrosis, and increased the release of TNF-α, IL-6, and IL-1β in VX2 liver cancer in rabbits. There was no significant impact on liver and kidney function in the tumor-bearing rabbits. Conclusion This study confirms that ozone water administered via hepatic artery infusion in VX2 liver cancer-bearing rabbits is an effective and safe approach, warranting further research and exploration

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-01-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司